Saliva Biochips for Cancer Detection
Non-small-cell lung carcinoma (NSCLC) is often fatal because most cases are diagnosed at an advanced stage preventing surgical intervention. Professor Wu-Chou Su (Department of Internal Medicine) collaborated with UCLA, and is currently conducting clinical research in the United States, China, and Taiwan on nano biochips using saliva tests to detect diseases. The accuracy rate of predicting stage 3 and 4 lung adenocarcinomas was 90%, and that of stage 1 and 2 lung adenocarcinomas was approximately 70%. This new technology tests the blood or saliva of early-stage lung cancer patients to identify two cancer-linked mutations discunssedin a study published in The Journal of Molecular Diagnostics.
Thinner, Faster and More Power-efficient
Intel Corp co-founder Gordon Moore developed Moore’s Law in 1965, which predicted that the number of Transistors on a chip would double every 18 to 24 months. It has since become a guiding principle in the computer chip industry. However, in the past few years, the physical transistor channel size limit has been reached, and the consequent challenges faced by the industry have given rise to questions as to whether the speed of innovation suggested by the law may have ended. Professor Chung-Lin Wu (Department of Physics) and Dr. Chia-Hao Chen have successfully extended and potentially laid the groundwork for going beyond Moore’s Law with a monolayer diode, which could lead to a breakthrough in the semiconductor industry. Their research published in Nature Communications, discusses the development of a 2D monolayer diode.